Study cohort
| Diagnosis | Number of cases (%) | Degree of dysplasia | Cases with PDAC | |
| Low-grade | High-grade | |||
| PanIN | 55/132 (41.7%) | 43/55 (78.2%) | 12/55 (21.8%) | 34/55 (61.8%) |
| IPMN gastric | 46/132 (34.8%) | 35/46 (76%) | 11/46 (23.9%) | 15/46 (32.6%) |
| IPMN intestinal | 21/132 (15.9%) | 8/21 (38%) | 13/21 (62%) | 7/21 (33.3%) |
| IPMN pancreatobiliary | 3/132 (2.3%) | 0 | 3/3 (100%) | 2/3 (66.6%) |
| IPMN mixed | 7/132 (5.3%) | 7/7 (100%) | 0 | 1/7 (14.3%) |
IPMN, intraductal papillary mucinous neoplasms; PanIN, pancreatic intraepithelial neoplasias; PDAC, pancreatic ductal adenocarcinoma.